#COVID19 Good @Reuters special report on the race for a #coronavirus vaccine with a discussion of key players, timelines, at-risk manufacturing and BARDA funding.

Companies mentioned: $JNJ $GSK $SNY $MRNA $BNTX $PFE $TBIO $ARCT CanSino &amp; SinoVac

https://t.co/9wMZID8rDp